Sept 21 (Reuters) - Neuren Pharmaceuticals Ltd (NEU) :
- SUBMITS IND APPLICATION FOR NNZ-2591 IN PHELAN-MCDERMID SYNDROME
News: NEU Neuren Pharmaceuticals Submits IND Application For NNZ-2591 In Phelan-Mcdermid Syndrome
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$13.16 |
Change
-0.490(3.59%) |
Mkt cap ! $1.696B | |||
| Open | High | Low | Value | Volume |
| $13.68 | $13.68 | $13.12 | $2.711M | 202.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1031 | $13.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.16 | 462 | 13 |
View Market Depth
| Last trade - 15.07pm 18/09/2024 (20 minute delay) ? |
| NEU (ASX) Chart |